Nasal Congestion News and Research

RSS

X-ray measurements help determine whether chronic problems with the hard-to-reach frontal sinuses can be corrected with surgery

"The frontal sinus is behind the forehead and it has a very tortuous drainage," says Dr. Stil E. Kountakis, vice chair of the Medical College of Georgia Department of Otolaryngology-Head and Neck Surgery. "It's the most difficult sinus to work with."

6 Jul 2005

Claritin's switch to OTC status meant fewer prescriptions

After the allergy drug Claritin became available without a prescription in 2002, insurance plans and consumers spent less on the prescription form of its main ingredient, loratadine, and all similar allergy drugs, according to a new report published in this month’s The American Journal of Managed Care.

10 Jun 2005

Studies show Pfizer's Azithromycin Microspheres effective as treatment for respiratory tract infections

Pfizer Inc.'s new investigational microsphere formulation of azithromycin, which is dosed as a one-time-only oral antibiotic, is comparable to other frequently prescribed treatments for some of the most common respiratory tract infections in adult patients.

1 Nov 2004

Sinusitis and bronchitis account for more than 30 million missed workdays each year

Sinusitis and bronchitis take a significant toll on a person's ability to participate in everyday life and have a sizable economic impact, accounting for more than 30 million missed workdays each year

21 Oct 2004

Ranbaxy receives FDA approval to market Loratadine and Pseudoephedrine Sulfate extended release tablets

Ranbaxy Pharmaceuticals, a wholly-owned subsidiary of Ranbaxy Laboratories Limited of New Delhi, India, announced today that RLL has received approval from the U. S. Food and Drug Administration to manufacture and market Loratadine and Pseudoephedrine Sulfate Extended Release Tablets

26 Sep 2004

Patients with asthma have a higher incidence of nasal polyposis, nasal congestion, and olfactory disturbances

Some 37 million Americans suffer from sinusitis; some of those patients are unfortunate enough to also have asthma, an inflammatory disease of the lungs characterized by reversible airway obstruction.

18 Sep 2004

A new lipid-based nasal ointment effective at reducing symptoms of allergic rhinitis

One in five Americans have allergic rhinitis, a number that is steadily rising, but the exact reasons for this increase are unknown. A new lipid-based nasal ointment is found effective at reducing symptoms of allergic rhinitis in German patients.

18 Sep 2004

Study suggests that patients with pulmonary arterial hypertension may benefit from Thelin therapy

Encysive Pharmaceuticals today announced the presentation of data from a clinical study of Thelin(TM) (sitaxsentan) in pulmonary arterial hypertension (PAH), at the European Society of Cardiology Annual Congress in Munich.

31 Aug 2004

Nasal cream effective in reducing the symptoms of allergic rhinitis

A nasal cream applied to the inside of the nose appears effective in reducing the symptoms of allergic rhinitis, according to an article in the August issue of The Archives of Otolaryngology – Head & Neck Surgery.

16 Aug 2004

Intranasal influenza vaccine may help induce broader immunity in children than the traditional flu shot

MedImmune, Inc. has announced clinical data showing that a live, attenuated intranasal influenza vaccine (LAIV) may help induce broader immunity in children against drifted influenza strains when compared to the traditional flu shot (TIV).

2 May 2004

New research into World Trade Center firefighter respiratory symptoms

Researchers from New York and the Centers for Disease Control and Prevention in Ohio found that arrival time and length of exposure to the World Trade Center (WTC) disaster were significant predictors of respiratory symptoms and lung function decline among firefighters.

12 Apr 2004

Study shows Levitra enhances patients' self-esteem by improving erections

The first clinical study to evaluate LEVITRA™ (vardenafil HCl) in men with mild Major Depressive Disorder (MDD) and erectile dysfunction (ED) showed LEVITRA produced statistically significant improvements over baseline in all measures of erectile function (EF) and depression/self-esteem. In the study, men taking Levitra were nearly three times more likely to report improved erections than men taking placebo.

24 Mar 2004

Forward step in treatment of Allergic Rhinitis

Rigel Pharmaceuticals, Inc. has announced the presentation of clinical data for R112, the company’s lead candidate for the treatment of allergic rhinitis, during a poster session at the annual meeting of the American Academy of Allergy, Asthma and Immunology (AAAAI) in San Francisco, CA. The phase I/II single dose trial demonstrated that R112 was well tolerated and showed favorable biological effects.

22 Mar 2004